NasdaqGS - Nasdaq Real Time Price
USD
Kiniksa Pharmaceuticals International, plc (KNSA)
64.21
+1.80
(+2.88%)
As of 12:54:38 PM EDT. Market Open.
Trade KNSA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for KNSA
- Previous Close
62.41 - Open
62.41 - Bid 46.32 x 200
- Ask 79.50 x 200
- Day's Range
61.60 - 64.81 - 52 Week Range
26.27 - 64.81 - Volume
486,248 - Avg. Volume
789,819 - Market Cap (intraday)
4.94B - Beta (5Y Monthly) 0.12
- PE Ratio (TTM)
70.55 - EPS (TTM)
0.91 - Earnings Date (est.) Jul 28, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
65.12
Recent News
View More
Performance Overview
Trailing total returns as of 6/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
KNSA
55.65%
S&P 500 (^GSPC)
9.54%
1-Year Return
KNSA
132.04%
S&P 500 (^GSPC)
20.84%
3-Year Return
KNSA
356.00%
S&P 500 (^GSPC)
68.49%
5-Year Return
KNSA
360.91%
S&P 500 (^GSPC)
74.48%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/29/2026
-
Market Cap
4.80B
-
Enterprise Value
4.34B
-
Trailing P/E
68.58
-
Forward P/E
56.82
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
6.67
-
Price/Book (mrq)
7.93
-
Enterprise Value/Revenue
5.76
-
Enterprise Value/EBITDA
45.76
Financial Highlights
Profitability and Income Statement
-
Profit Margin
9.69%
-
Return on Assets (ttm)
8.18%
-
Return on Equity (ttm)
13.74%
-
Revenue (ttm)
754.04M
-
Net Income Avi to Common (ttm)
73.06M
-
Diluted EPS (ttm)
0.91
Balance Sheet and Cash Flow
-
Total Cash (mrq)
468.09M
-
Total Debt/Equity (mrq)
1.49%
-
Levered Free Cash Flow (ttm)
117.57M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
64.21
+2.88%
Mkt Cap
4.94B
Industry
Drug Manufacturers—Specialty & Generic
20.09
-2.99%
Mkt Cap
885.827M
Industry
Drug Manufacturers—Specialty & Generic
40.92
-0.82%
Mkt Cap
4.837B
Industry
Drug Manufacturers—Specialty & Generic
18.49
-1.12%
Mkt Cap
2.056B
Industry
Drug Manufacturers—Specialty & Generic
1.0550
+2.43%
Mkt Cap
121.612M
Industry
Drug Manufacturers—Specialty & Generic
542.15
-0.51%
Mkt Cap
23.012B
Industry
Drug Manufacturers—Specialty & Generic
17.31
+0.09%
Mkt Cap
5.521B
Industry
Drug Manufacturers—Specialty & Generic
4.2800
-0.47%
Mkt Cap
704.545M
Industry
Drug Manufacturers—Specialty & Generic
83.54
-0.69%
Mkt Cap
1.899B
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
